Cargando…

The Diverse Consequences of FOXC1 Deregulation in Cancer

Forkhead box C1 (FOXC1) is a transcription factor with essential roles in mesenchymal lineage specification and organ development during normal embryogenesis. In keeping with these developmental properties, mutations that impair the activity of FOXC1 result in the heritable Axenfeld-Rieger Syndrome...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gilding, L. Niall, Somervaille, Tim C. P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406774/ https://www.ncbi.nlm.nih.gov/pubmed/30764547 http://dx.doi.org/10.3390/cancers11020184

Ejemplares similares

Impact of OGT deregulation on EZH2 target genes FOXA1 and FOXC1 expression in breast cancer cells
por: Forma, Ewa, et al.
Publicado: (2018)

FOXC1, the new player in the cancer sandbox
por: Elian, Fahed A., et al.
Publicado: (2017)

Transposable Elements in Human Cancer: Causes and Consequences of Deregulation
por: Anwar, Sumadi Lukman, et al.
Publicado: (2017)

Deregulated Metabolic Pathways in Ovarian Cancer: Cause and Consequence
por: Murali, Roopak, et al.
Publicado: (2023)

Foxc1 and Foxc2 in the Neural Crest Are Required for Ocular Anterior Segment Development
por: Seo, Seungwoon, et al.
Publicado: (2017)

Loss of Foxc1 and Foxc2 function in chondroprogenitor cells disrupts endochondral ossification
por: Almubarak, Asra, et al.
Publicado: (2021)

Enhancer recruitment of transcription repressors RUNX1 and TLE3 by mis-expressed FOXC1 blocks differentiation in acute myeloid leukemia
por: Simeoni, Fabrizio, et al.
Publicado: (2021)

Endothelial FOXC1 and FOXC2 promote intestinal regeneration after ischemia–reperfusion injury
por: Tan, Can, et al.
Publicado: (2023)

FOXC1 in cancer development and therapy: deciphering its emerging and divergent roles
por: Yang, Zhi, et al.
Publicado: (2017)

Regulation and Function of FOXC1 in Osteoblasts
por: Suthon, Sarocha, et al.
Publicado: (2023)

FOXC1: an emerging marker and therapeutic target for cancer
por: Han, Bingchen, et al.
Publicado: (2017)

Shear stimulation of FOXC1 and FOXC2 differentially regulates cytoskeletal activity during lymphatic valve maturation
por: Norden, Pieter R, et al.
Publicado: (2020)

All eyes on FOXC2
por: Yan, Wei, et al.
Publicado: (2023)

Foxc1 and Foxc2 function in osteochondral progenitors for the progression through chondrocyte hypertrophy and mineralization of the primary ossification center
por: Almubarak, Asra, et al.
Publicado: (2023)

FOXC2 Promotes Vasculogenic Mimicry in Ovarian Cancer
por: Recouvreux, Maria Sol, et al.
Publicado: (2022)

Cdt1 revisited: complex and tight regulation during the cell cycle and consequences of deregulation in mammalian cells
por: Fujita, Masatoshi
Publicado: (2006)

Deregulation of Rho GTPases in cancer
por: Porter, Andrew P., et al.
Publicado: (2016)

FOXC1 plays a crucial role in the growth of pancreatic cancer
por: Subramani, Ramadevi, et al.
Publicado: (2018)

FOXC1 Binds Enhancers and Promotes Cisplatin Resistance in Bladder Cancer
por: Lu, Yi-Tsung, et al.
Publicado: (2022)

Foxc2 is essential for podocyte function
por: Nilsson, Daniel, et al.
Publicado: (2019)

FOXC1 and FOXC2 maintain mitral valve endothelial cell junctions, extracellular matrix, and lymphatic vessels to prevent myxomatous degeneration
por: Tan, Can, et al.
Publicado: (2023)

Foxc1 is required by pericytes during fetal brain angiogenesis
por: Siegenthaler, Julie A., et al.
Publicado: (2013)

The Role of FoxC2 Transcription Factor in Tumor Angiogenesis
por: Kume, Tsutomu
Publicado: (2012)

Should We Consider Cancers as Embryonic Diseases or as Consequences of Stem-Cell Deregulation?
por: Bastid, Jérémy, et al.
Publicado: (2008)

Prenylation Defects and Oxidative Stress Trigger the Main Consequences of Neuroinflammation Linked to Mevalonate Pathway Deregulation
por: Pisanti, Simona, et al.
Publicado: (2022)

Deregulation of Transcriptional Enhancers in Cancer
por: Mirzadeh Azad, Fatemeh, et al.
Publicado: (2021)

Epigenetic Deregulation of Apoptosis in Cancers
por: Ozyerli-Goknar, Ezgi, et al.
Publicado: (2021)

Uncapping and Deregulation of Telomeres Lead to Detrimental Cellular Consequences in Yeast
por: Smith, Christopher D., et al.
Publicado: (1999)

FOXC2-AS1/FOXC2 axis mediates matrix stiffness-induced trans-differentiation of hepatic stellate cells into fibrosis-promoting myofibroblasts
por: Sun, Liankang, et al.
Publicado: (2023)

Mechanistic Insights into Axenfeld–Rieger Syndrome from Zebrafish foxc1 and pitx2 Mutants
por: French, Curtis R.
Publicado: (2021)

MYOC and FOXC1 gene analysis in primary congenital glaucoma
por: Tanwar, Mukesh, et al.
Publicado: (2010)

Foxc1 establishes enhancer accessibility for craniofacial cartilage differentiation
por: Xu, Pengfei, et al.
Publicado: (2021)

Meta-analysis of the prognostic significance of FOXC2 in various tumors
por: Xu, Bixia, et al.
Publicado: (2019)

LSD1: biologic roles and therapeutic targeting
por: Maiques-Diaz, Alba, et al.
Publicado: (2016)

Structural basis for DNA recognition by FOXC2
por: Chen, Xiaojuan, et al.
Publicado: (2019)

Epigenetic gene deregulation in cancer
por: Malik, K, et al.
Publicado: (2000)

LncRNA FOXC2-AS1 enhances FOXC2 mRNA stability to promote colorectal cancer progression via activation of Ca(2+)-FAK signal pathway
por: Pan, Ke, et al.
Publicado: (2020)

Chromatin deregulation in disease
por: Mirabella, Anne C., et al.
Publicado: (2015)

Immunometabolism features of metabolic deregulation and cancer
por: Wang, Xue, et al.
Publicado: (2018)

MYC Deregulation in Primary Human Cancers
por: Kalkat, Manpreet, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nhhrdknhe3vrf2ji2s670dba94